Mifeprex:
Korlym:
Contraindicated in:
Use Cautiously in:
CV: hypertension (Korlym), peripheral edema (Korlym), QT interval prolongation (Korlym).
Derm: rash (Korlym).
Endo: hypothyroidism (Korlym), ↓ HDL cholesterol (Korlym), adrenal insufficiency (Korlym).
F and E: hypokalemia (Korlym).
GI: abdominal pain (Mifeprex), anorexia (Korlym), constipation (Korlym), diarrhea, dry mouth (Korlym), nausea, vomiting.
GU: uterine bleeding, uterine cramping (Mifeprex), pelvic pain (Mifeprex), ruptured ectopic pregnancy (Mifeprex).
MS: arthralgia (Korlym), myalgia (Korlym).
Neuro: anxiety (Korlym), dizziness, fatigue (Korlym), headache, fainting (Mifeprex), weakness (Mifeprex).
Resp: dyspnea (Korlym), Pneumocystis jirovecipneumonia.
Misc: ANGIOEDEMA.
Drug-Drug:
Drug-Natural Products:
Drug-Food:
Mifeprex
Korlym
Renal Impairment
Hepatic Impairment
Therapeutic Classification: abortifacients, antidiabetics
Pharmacologic Classification: antiprogestational agents
Absorption: Rapidly absorbed following oral administration (69% bioavailability); absorption enhanced with food.
Distribution: Unknown.
Protein Binding: 98%.
Metabolism/Excretion: Primarily metabolized by the liver via the CYP3A4 isoenzyme; primarily excreted in the feces.
Half-life: 18 hr.
NDC Code*